We are live on ! Find out more
CTA

Carillon Tower Advisers Portfolio holdings

AUM $16.4B
1-Year Est. Return 64.75%
This Fund
S&P 500
This Quarter Est. Return
+7.33%
1 Year Est. Return
+64.75%
3 Year Est. Return
+147.06%
5 Year Est. Return
10 Year Est. Return
AUM
$12.7B
AUM Growth
-$159M
Cap. Flow
+$1.08B
Cap. Flow %
8.52%
Top 10 Hldgs %
10.09%
Holding
527
New
73
Increased
203
Reduced
139
Closed
69

Top Sells

Rank Stock Value
1
BURL icon
Burlington
BURL
+$70.3M
2
WCN
Waste Connections
WCN
+$61.3M
3
AYI icon
Acuity Brands
AYI
+$56.2M
4
JBLU icon
JetBlue
JBLU
+$54.3M
5
MLM icon
Martin Marietta Materials
MLM
+$53.3M

Sector Composition

Rank Sector Weight
1 Healthcare 19.28%
2 Technology 18.45%
3 Industrials 14.15%
4 Consumer Discretionary 14.07%
5 Financials 10.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HCSG icon
401
Healthcare Services Group
HCSG
$1.61B
$3.71M 0.03%
85,786
+11,774
+16% +$467K
ADI icon
402
Analog Devices
ADI
$172B
$3.69M 0.03%
38,425
-90,327
-70% -$8.53M
DOX icon
403
Amdocs
DOX
$6.03B
$3.69M 0.03%
55,700
+18,357
+49% +$1.24M
CAKE icon
404
Cheesecake Factory
CAKE
$5.03B
$3.64M 0.03%
66,167
-883
-1% -$46.7K
GIII icon
405
G-III Apparel Group
GIII
$1.54B
$3.51M 0.03%
78,996
+146
+0.2% +$5.93K
BNY
406
Bank of New York Mellon
BNY
$103B
$3.42M 0.03%
+63,400
New +$3.5M
CUTR
407
DELISTED
Cutera, Inc.
CUTR
$3.41M 0.03%
84,661
+19,371
+30% +$892K
INWK
408
DELISTED
InnerWorkings, Inc.
INWK
$3.39M 0.03%
389,611
+124,628
+47% +$1.15M
PETS icon
409
PetMed Express
PETS
$42.3M
$3.37M 0.03%
+76,500
New +$2.96M
PRAA icon
410
PRA Group
PRAA
$672M
$3.29M 0.03%
85,242
+1,210
+1% +$46.7K
LGIH icon
411
LGI Homes
LGIH
$1.35B
$3.28M 0.03%
56,758
-717
-1% -$46.2K
ROK icon
412
Rockwell Automation
ROK
$51.1B
$3.2M 0.03%
19,275
-28,825
-60% -$5.01M
VRTU
413
DELISTED
Virtusa Corporation
VRTU
$3.19M 0.03%
65,593
-957
-1% -$46.5K
CNO icon
414
CNO Financial Group
CNO
$4.94B
$3.19M 0.03%
167,276
-45,699
-21% -$946K
HMSY
415
DELISTED
HMS Holdings Corp.
HMSY
$3.17M 0.03%
146,646
-10,229
-7% -$207K
ADM icon
416
Archer Daniels Midland
ADM
$38.7B
$3.13M 0.02%
+68,200
New +$3.06M
VREX icon
417
Varex Imaging
VREX
$462M
$3.09M 0.02%
83,413
-237
-0.3% -$8.76K
TT icon
418
Trane Technologies
TT
$98.8B
$2.95M 0.02%
+32,900
New +$2.89M
DIS icon
419
Walt Disney
DIS
$171B
$2.9M 0.02%
+27,700
New +$2.83M
HTH icon
420
Hilltop Holdings
HTH
$2.26B
$2.9M 0.02%
131,459
+8,384
+7% +$195K
WMT icon
421
Walmart Inc
WMT
$909B
$2.8M 0.02%
+98,100
New +$2.79M
FN icon
422
Fabrinet
FN
$14.9B
$2.8M 0.02%
75,826
-974
-1% -$33.3K
AMBA icon
423
Ambarella
AMBA
$3.04B
$2.66M 0.02%
68,912
-1,488
-2% -$70.4K
BIG
424
DELISTED
Big Lots, Inc.
BIG
$2.6M 0.02%
62,175
-47,675
-43% -$2M
OSK icon
425
Oshkosh
OSK
$8.91B
$2.51M 0.02%
+35,700
New +$2.67M

Similar funds

Carillon Tower Advisers's Q2 2018 Portfolio in Review

As of Q2 2018, Carillon Tower Advisers held 527 positions worth $12.7B, down 1.2% from $12.9B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Carillon Tower Advisers deployed $1.08B of net new capital in Q2 2018, opening 73 new positions and adding to 203 existing holdings. Its largest new stake was WW International: 726,252 shares worth $73.4M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Burlington, an estimated $70.3M trimmed.

  • Carillon Tower Advisers's largest Q2 2018 buy was WW International: 726,252 shares worth $73.4M.
  • Carillon Tower Advisers added most to Abiomed Inc in Q2 2018, an estimated $63.1M increase.
  • Carillon Tower Advisers's biggest Q2 2018 reduction was Burlington, cutting an estimated $70.3M.
  • Carillon Tower Advisers fully exited Acuity Brands in Q2 2018, selling an estimated $56.2M.
  • Carillon Tower Advisers's ten largest holdings make up 10% of its $12.7B portfolio in Q2 2018.
  • Carillon Tower Advisers opened 73 new positions and closed 69 in Q2 2018.
  • Carillon Tower Advisers's portfolio value fell 1.2% quarter-over-quarter to $12.7B.

Based on Carillon Tower Advisers's 13F filing for Q2 2018, filed 9 Aug 2018.